​

Bicara Therapeutics Ownership | Who Owns Bicara Therapeutics?

OverviewFinancialsChart

Bicara Therapeutics Ownership Summary

Bicara Therapeutics is owned by 85.84% institutional investors, 0.42% insiders, and 13.74% retail investors. Spire wealth management is the largest institutional shareholder, holding 0% of BCAX shares.

BCAX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBicara Therapeutics85.84%0.42%13.74%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Spire wealth management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Spire wealth management---

Top Buyers

HolderShares% AssetsChange
Spire wealth management---1.80K

Top Sellers

HolderShares% AssetsChange
Spire wealth management---1.80K

Sold Out

HolderChange
Spire wealth management-1.80K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20248322.06%46,705,50728.51%851.92%62-8.82%7-
Sep 30, 202468-36,343,123-66-68---

Recent Insider Transactions

DateNameRoleActivityValue
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$615.70K
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$405.51K
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$30.25M
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$2.74M
Sep 17, 2024Flynn James E Possible Members of 10% GroupBuy$630.00K

Insider Transactions Trends

DateBuySell
2024 Q33-

BCAX Ownership FAQ

Who Owns Bicara Therapeutics?

Bicara Therapeutics shareholders are primarily institutional investors at 85.84%, followed by 0.42% insiders and 13.74% retail investors. The average institutional ownership in Bicara Therapeutics's industry, Biotech Stocks , is 68.48%, which Bicara Therapeutics exceeds.

Does Blackrock own Bicara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicara Therapeutics.

Who is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested?

Spire wealth management is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Bicara Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools